QA: Veracyte INC in us_health_services/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001384101_2026_Veracyte_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.4651917835200234, 'aggregate_val': 461216000, 'exp_sum': 314782000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 110784000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 100165000, 'ResearchAndDevelopmentExpense': 70814000, 'remainder_Expenses': 33019000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001384101, Veracyte INC

  xvar xval
0 IntangibleAssets 856,302,000
1 AssetsNonCurrent 37,501,000
2 AssetsCurrent 488,376,000
3 PropertyPlantAndEquipment 22,192,000
4 remainder_Assets 1,648,000
5 LongTermLiabilities 35,603,000
6 LiabilitiesCurrent 60,583,000
7 remainder_Liabilities 257,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 110,784,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 100,165,000
15 ResearchAndDevelopmentExpense 70,814,000
16 remainder_Expenses 179,453,000
17 remainder_Revenues 517,145,000
18 remainder_NetIncome 10,424,000
19 remainder_ComprehensiveNetIncome 27,878,000
  yvar yval
0 Assets 1,406,019,000
1 Liabilities 96,443,000
2 Expenses 461,216,000
3 Revenues 517,145,000
4 StockholdersEquity 1,309,576,000
5 NetIncome 66,353,000
6 ComprehensiveNetIncome 94,231,000
7 BaseVar 1,259,562,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.65
9 EconomicCapitalRatio 2.86

Edgar->Model Mapping

Feature Distribution

Change over Time